USE OF 3-(4-AMINO-1-OXO-1, 3-DIHYDROISOINDOL-2-YL)PIPERIDINE-2,6-DIONE FOR TREATING MANTLE CELL LYMPHOMAS Russian patent published in 2012 - IPC A61K31/454 A61P35/00

Abstract RU 2446804 C2

FIELD: medicine, pharmaceutics.

SUBSTANCE: group of inventions refers to medicine, namely oncology, and may be used for treating recurrent, refractory or drug-refractory mantle cell lymphoma. Methods under the invention involve the introduction of 3-(4-amino-1-oxo-1,3-dihydroizoindol-2-yl)piperidine-2,6-dione.

EFFECT: use of the invention enables higher effectiveness in recurrent, refractory or drug-refractory mantle cell lymphoma.

13 cl, 1 ex

Similar patents RU2446804C2

Title	Year	Author	Number
METHODS FOR ADMINISTRATION OF 3-(4-AMINO-1-OXO-1,3-DIHYDROISOINDOLE-2-YL)PIPERIDINE-2,6-DIONE IN CERTAIN TYPES OF LEUKEMIA	2006	Zeldis Dzherom B.	RU2406501C2
METHODS AND COMPOSITIONS USING IMMUNOMODULATORY COMPOUNDS FOR TREATMENT AND MAINTENANCE OF CANCER AND OTHER DISEASES	2004	Zeldis Dzherom B.	RU2348407C2
METHODS AND COMPOSITIONS WITH APPLICATION OF IMMUNOMODELLING COMPOUNDS IN COMBINED TREATMENT	2007	Verell' Dominik Chan' Kajl Korral Lora Mutu De Parseval' Lor Brehdi Khelen	RU2426542C2
SOLID FORMS OF 3-(5-AMINO-2-METHYL-4-OXO-4H-QUINAZOLIN-3-YL)PIPERIDINE-2,6-DIONE DERIVATIVES AND THEIR PHARMACEUTICAL COMPOSITIONS AND USE	2012	Myuller Dzhordzh V. Man Khon-Vakh Koen Bendzhamin M. Li In Syuj Dzhin Leong Uillyam V.	RU2611007C2
DOSAGE FORMS OF HISTONE DEACETYLASE INHIBITOR IN COMBINATION WITH BENDAMUSTINE AND THEIR APPLICATION	2011	Lauri Devid Dzh. Bagi Dzhozef Dzh. Modi Tarak D. Verner Erik Dzh. Purro Norbert Balasubramanian Sriram Kloos Joanna Depil Stefan	RU2609833C2
PREPARATIONS OF {2-[(1S)-1-(3-ETHOXY-4-METHOXYPHENYL)-2-METHANESULFONYLETHYL]-3-OXO-2,3-DIHYDRO-1H-ISOINDOL-4-YL} AMIDE OF CYCLOPROPANECARBOXYLIC ACID	2012	Beursen Nejtan Li Vaj Ip Khyui Kho-Vakh Kurtulik Pol	RU2627471C2
FORMULATION OF 4-AMINO-2-(2,6-DIOXOPIPERIDIN-3-YL)ISOINDOLINE-1,3-DIONE	2010	Tatino Ehntoni Kelli Majkl T.	RU2479307C1
TREATMENT OF B-CELLULAR MALIGNANT TUMORS USING ANTI-CD40L ANTIBODIES IN COMBINATION WITH ANTI-CD20 ANTIBODIES AND/OR BY CHEMOTHERAPY AND RADIOTHERAPY	2000	Khanna Nabil Kharikharan Kandasami	RU2305561C2
COMBINATION OF CHEKPOINT-KINASE 1 INHIBITORS AND WEE 1 KINASE INHIBITORS	2011	Dejvis Kertis D. Gros Stefan	RU2627841C2
6-, 7- OR 8-SUBSTITUTED QUINAZOLINONE DERIVATIVES AND COMPOSITIONS CONTAINING THEM AND METHODS OF USING THEM	2008	Mjuller Dzhordzh V. Man Khon-Vakh	RU2476432C2

RU 2 446 804 C2

Authors

Zeldis Dzherom B.

Dates

2012-04-10—Published

2007-08-02—Filed